Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
228.3 USD | +1.27% |
|
-0.35% | -11.50% |
01:00pm | US FDA advisers to review Eli Lilly Alzheimer's drug | RE |
09:44am | Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.50% | 32.82B | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
+64.89% | 26.66B | |
-13.54% | 15.32B | |
-5.97% | 13.3B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B | |
+2.32% | 9.06B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating